ACCESSWIRE
09 May 2022, 21:37 GMT+10
MINNEAPOLIS, MN / ACCESSWIRE / May 9, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, today announced that it will release its financial results for the first quarter 2022 after the stock market close on Monday, May 16, 2022. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
Webcast and Conference Call Information
To participate in the teleconference, domestic callers should dial 1-844-825-9789 and international callers should dial 1-412-317-5180 and reference conference ID: 10166506. A live webcast presentation can also be accessed using this weblink: https://viavid.webcasts.com/starthere.jsp?ei=1545538&tp_key=5a345444e1. A replay of the webcast will be available on the Celcuity website following the live event.
About Celcuity
Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic and companion diagnostic strategy. The company's lead therapeutic candidate is gedatolisib, a potent, reversible dual inhibitor that selectively targets all Class I isoforms of PI3K and mTOR. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. The company expects to initiate a Phase 3 study evaluating gedatolisib in patients with HR+/HER2- advanced breast cancer in 2022. Its CELsignia companion diagnostic platform is uniquely able to analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from already approved targeted therapies. Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at www.celcuity.com.
Contacts:
Celcuity Inc.
Brian Sullivan, bsullivan@celcuity.com
Vicky Hahne, vhahne@celcuity.com
763-392-0123
ICR Westwicke
Robert Uhl, robert.uhl@westwicke.com
(619) 228-5886
SOURCE: Celcuity Inc.
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationNEW YORK, New York - Bargain-hunters drove up the prices of stocks on U.S. markets on Tuesday."Our inputs today support ...
NEW DELHI, India: India has banned the exporting of wheat, despite stating it was targeting record international shipments this year, ...
NEW DELHI, India: Tesla made known this week that it will not sell electric automobiles in India due to the ...
SYDNEY, NSW, Australia - A potential easing of the Chinese government's crackdown on technology companies drove stocks in Hong Kong ...
KATHMANDU, Nepal - The governments of Nepal and India have signed a bilateral memorandum of understanding for the construction of ...
LOS ANGELES, California: Kia has become the second largest manufacturer of electric vehicles sold in the United States, second only ...
NEW YORK CITY, New York: Amazon.com founder Jeff Bezos delivered a tearful remembrance of his father's fleeing Cuba in the ...
The Cincinnati Reds pushed across the winning run on a bases-loaded walk to Mike Moustakas to defeat the host Cleveland ...
After a pair of unfortunate results -- falling to the San Jose Earthquakes and then losing to Minnesota United FC ...
Milwaukee Brewers pitcher J.C. Mejia was suspended for 80 games Tuesday for violating Major League Baseball's Joint Drug Prevention and ...
Washington - The political sway of former U.S. President Donald Trump over Republican Party politics 16 months after he left ...
The New York Red Bulls are doing enough to contribute to a crowded race at the top of the Eastern ...